INmune Bio Total Assets

INmune Bio (INMB) currently reports a total assets of $27M as of June 2026. That compares with $38M in the prior-year period — down 28.8% year over year. Use the charts on this page to explore INmune Bio's total assets history and peer comparisons.

INmune Bio's total assets decreased from $38M to $27M — a 28.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

INmune Bio reported $27M in total assets as of June 2026. That compares with $38M in the prior-year period — down 28.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $27M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for INmune Bio, and consider following INMB for alerts when major investors trade the stock.

INmune Bio is classified in the Healthcare sector. On total assets, it currently shows $27M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INMB with unrelated industries.